Yarrow Bioscience YARW
NASDAQ YARW
$29.11 -0.19 (-0.65%)
At close: Sep 9, 2026 · 4:00 PM EDT

Yarrow Bioscience (YARW) Net Shares Issued and Repurchased (2016 - 2020)

Yarrow Bioscience's (YARW) quarterly Net Shares Issued and Repurchased came in at $1.5 million in Q1 2020, up 1245.68% on a YoY basis from $108881.0 in Q2 2019, and up 181.31% quarter-over-quarter from $520850.0 in Q4 2019.

Analysis

Yarrow Bioscience (YARW) Net Shares Issued and Repurchased (2016 - 2020) Analysis & Trends

Yarrow Bioscience (YARW) has reported Net Shares Issued and Repurchased for 5 consecutive years, with $1.5 million the latest figure, recorded in Q1 2020.

  • For the quarter ending Q1 2020, Net Shares Issued and Repurchased rose 1245.68% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2020 stood at $1.5 million (up 1245.68% YoY), and the FY2019 full-year result was $520850.0, down 69.36% from the prior year.
  • Net Shares Issued and Repurchased rose to $1.5 million in Q1 2020 per YARW's latest filing, from $520850.0 in the prior quarter.
  • Across five years, Net Shares Issued and Repurchased topped out at $1.7 million in Q4 2018 and bottomed at $108881.0 in Q1 2019.
  • Historically, Net Shares Issued and Repurchased has averaged $1.1 million across 5 years, with a median of $1.3 million in 2017.
  • The sharpest annual moves came in 2019 and 2020: Net Shares Issued and Repurchased plunged 69.36% in 2019, then soared 1245.68% in 2020.
  • Over 5 years, Net Shares Issued and Repurchased stood at $1.5 million in 2016, then dropped by 29.95% to $1.0 million in 2017, then soared by 63.41% to $1.7 million in 2018, then slumped by 69.36% to $520850.0 in 2019, then soared by 181.31% to $1.5 million in 2020.
  • According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $1.5 million, $520850.0, and $108881.0 for Q1 2020, Q4 2019, and Q1 2019 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn -
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -3.07 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -
7 Revolution Medicines 43.79 Bn 43.79 Bn - -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn -
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn -
10 Yarrow Bioscience 25.25 Mn 2.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 1.47 Mn
Dec 31, 2019 520,850.00
Mar 31, 2019 108,881.00
Dec 31, 2018 1.70 Mn
Dec 31, 2017 1.04 Mn
Dec 31, 2016 1.49 Mn